Licui Jiang

410 total citations
8 papers, 212 citations indexed

About

Licui Jiang is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Licui Jiang has authored 8 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Licui Jiang's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Licui Jiang is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Licui Jiang collaborates with scholars based in China and United Kingdom. Licui Jiang's co-authors include Lin Yang, Gangli An, Fengtao You, Huimin Meng, Dan Chen, Xuejun Zhu, Yinyan Wang, Lei Yuan, Bozhen Zhang and Jialu Li and has published in prestigious journals such as Cancer Research, Oncotarget and Heliyon.

In The Last Decade

Licui Jiang

8 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Licui Jiang China	6	182	150	37	34	24	8	212
Brian Groff United States	7	173 1.0×	147 1.0×	57 1.5×	33 1.0×	11 0.5×	17	218
Lester Lledo United States	8	126 0.7×	43 0.3×	29 0.8×	32 0.9×	19 0.8×	8	149
Lorena Pérez-Amill Spain	7	150 0.8×	131 0.9×	41 1.1×	20 0.6×	18 0.8×	11	200
Jinlong Xu China	6	139 0.8×	42 0.3×	37 1.0×	51 1.5×	41 1.7×	16	177
Nicola Mitwasi Germany	8	202 1.1×	87 0.6×	55 1.5×	53 1.6×	91 3.8×	15	225
Cheryl McAlpine United States	6	145 0.8×	154 1.0×	73 2.0×	24 0.7×	21 0.9×	12	254
Yue Tan China	6	151 0.8×	45 0.3×	39 1.1×	62 1.8×	29 1.2×	10	171
Gretchen E. Lyons United States	10	191 1.0×	252 1.7×	47 1.3×	65 1.9×	14 0.6×	11	312
Bruce L. Levine United States	4	158 0.9×	37 0.2×	75 2.0×	37 1.1×	27 1.1×	6	171
John Pineda United States	6	174 1.0×	50 0.3×	46 1.2×	68 2.0×	51 2.1×	11	206

Countries citing papers authored by Licui Jiang

Since Specialization

Citations

This map shows the geographic impact of Licui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licui Jiang more than expected).

Fields of papers citing papers by Licui Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Licui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licui Jiang. The network helps show where Licui Jiang may publish in the future.

Co-authorship network of co-authors of Licui Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Licui Jiang. A scholar is included among the top collaborators of Licui Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Licui Jiang. Licui Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Jiang, Licui, Fengtao You, Changsong Qi, et al.. (2024). B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors. Cancer Research. 84(23). 4066–4080. 7 indexed citations

2.

Jiang, Licui, Changsong Qi, Min Wang, et al.. (2024). Abstract 5255: A B7-H3-CAR-modified Vδ1 T cells showed potentanti-solid tumor potential. Cancer Research. 84(6_Supplement). 5255–5255. 1 indexed citations

3.

Zhang, Kailu, Zixuan Li, Tian Wang, et al.. (2023). CD7 protein plays a crucial role in T cell infiltration in tumors. Heliyon. 9(6). e16961–e16961. 3 indexed citations

4.

Zhang, Tingting, Tian Wang, Fengtao You, et al.. (2022). Nanobody-based anti-CD22-chimeric antigen receptor T cell immunotherapy exhibits improved remission against B-cell acute lymphoblastic leukemia. Transplant Immunology. 71. 101538–101538. 13 indexed citations

5.

You, Fengming, Shan Xiang, Yinyan Wang, et al.. (2021). Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.. PubMed. 11(11). 5263–5281. 10 indexed citations

6.

You, Fengtao, Licui Jiang, Dan Chen, et al.. (2021). MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.. American Journal of Cancer Research. 11(1). 79–91. 25 indexed citations

7.

You, Fengtao, Yinyan Wang, Licui Jiang, et al.. (2019). A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.. PubMed. 9(1). 64–78. 116 indexed citations

8.

Chen, Ying, Fengtao You, Licui Jiang, et al.. (2017). Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody. Oncotarget. 8(23). 37128–37139. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact